Scientific and innovative
About Almirall, LLC - U.S.
Noble purpose
Company details
Leadership team
The professional experience, educational preparation, energy, and enthusiasm of our US leadership team helps to explain our success.
Paul Rittman
President and General Manager of Almirall, LLC -- U.S.
35+ years pharmaceutical experience across sales, marketing research, marketing, commercial leadership and general management at Marion Laboratories (which became Aventis and then Sanofi), Intrabiotics, Teva Pharmaceuticals and Helsinn Therapeutics. BA in Psychology with minors in Chemistry and Biology from University of Missouri and an MBA from St. Ambrose University.
David Loughery
Chief Financial Officer of Almirall, LLC -- U.S.
30+ years of pharmaceutical experience at Rhone-Poulenc Rorer, Bristol-Myers Squibb, and Teva. B.A. in Economics, Rutgers University and M.B.A. in Finance,Temple University.
Biju Chorinchath
Head of US Marketing, Market Access, Channel and Business Development
20+ years of pharmaceutical experience at CSL Behring, Sobi, and Pfizer. MS in Health Policy and Management.
Domenick Dicindio
Head of Human Resources
30+ years of pharmaceutical experience at Almirall, Novartis, and Winthrop. MBA in Marketing and a BS in Business with an emphasis in Economics.
Glenn Cantagallo
Head of Sales and Commercial Operations
20+ years of pharmaceutical and medical device experience at Novo Nordisk and Abbott Laboratories. BA in Biology and Certificate of Development from Wharton.
Paul Tomondy
Head of Medical Affairs and R&D
20+ years of pharmaceutical medical affairs experience at Sanofi Genzyme, AbbVie, UCB and P&G. Pharm.D, B.S. in Pharmacy, and B.S. in Biology.
Wendy Jones
Head of Regulatory Affairs
20+ years of pharmaceutical and medical device regulatory experience at Merz and as an industry consultant. BS in Biology and Chemistry from Virginia Tech, RAC.
Kathryn Pryze
Head of Compliance
20+ years of pharmaceutical experience with a concentration in compliance at Endo and AstraZeneca. BA in Advertising; MS curriculum in Biomedical Science.
Financial reports
